The Cigna Group: AI Investment in Accredo Specialty Pharmacy

The Cigna Group has launched 'Pharmacy Forward', a $100 million AI-driven initiative for its Accredo specialty pharmacy platform. The program aims to generate $400 million in value by 2028 while significantly increasing operational efficiency.

Key Takeaways

• 1.The Cigna Group announced 'Pharmacy Forward', an AI-enabled specialty pharmacy platform with a $100 million investment through 2028.
• 2.The program targets $400 million in cumulative value creation by year-end 2028 through operational improvements.
• 3.Operational goals include cutting prescription processing timelines in half and reducing clinician documentation time by 50%.

Table of Contents

• The Cigna Group (CI): CI Invests Growth Capital to Advance AI Build-Out of Accredo's Specialty Pharmacy Growth Platform
• Key Details on Evernorth's Pharmacy Forward Program
• Valuation and Risks
• Disclosure Appendix

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial